Cefotaxime treatment of pelvic inflammatory disease.
We studied cefotaxime in the treatment of gonococcal and nongonococcal pelvic inflammatory disease. Cefotaxime was uniformly effective against gonococcal pelvic inflammatory disease. However, 4 of 11 patients with nongonococcal pelvic inflammatory disease had a suboptimal response.
D001419:Bacteria / Q000187:drug effects; D002439:Cefotaxime / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D009344:Neisseria gonorrhoeae / Q000187:drug effects; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy* / Q000382:microbiology
D002439:Cefotaxime